LENALIDOMIDE vs REVLIMID

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 18, 2026·How we rate

Attribute	LENALIDOMIDE	REVLIMID
Rating	70/100	72/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	LENALIDOMIDE	LENALIDOMIDE
Manufacturer	Cipla	Bristol Myers Squibb
Dosage forms	Capsule	Capsule
Drug class	Thalidomide Analog	Thalidomide Analog
Boxed warning	Boxed warning	Boxed warning
Half-life	about 3 hours in healthy subjects, and 3 to 5 hours in patients with multiple myeloma, MDS, or mantle cell lymphoma	about 3 hours in healthy subjects, and 3 to 5 hours in patients with multiple myeloma, MDS, or mantle cell lymphoma
Treats	Multiple Myeloma, Myelodysplastic Syndromes, Mantle-Cell Lymphoma	Multiple Myeloma, Myelodysplastic Syndromes, Mantle-Cell Lymphoma

lenalidomide revlimid

Rating

70/100

72/100

Pharmacy pays

—

Type

Active ingredient

LENALIDOMIDE

Manufacturer

Cipla

Bristol Myers Squibb

Dosage forms

Capsule

Drug class

Thalidomide Analog

Boxed warning

Half-life

about 3 hours in healthy subjects, and 3 to 5 hours in patients with multiple myeloma, MDS, or mantle cell lymphoma

Treats

Multiple Myeloma, Myelodysplastic Syndromes, Mantle-Cell Lymphoma

Frequently asked questions

Which is better-rated, Lenalidomide or Revlimid?

By our independent rating, Revlimid scores higher — 3.6 vs 3.5 out of 5 for Lenalidomide. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Lenalidomide and Revlimid?

Both Lenalidomide and Revlimid share the active ingredient Lenalidomide.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.